Friday, September 25, 2020

Johnson & Johnson COVID Vaccine Produces Strong Immune Response In Trial

A single dose of Johnson & Johnson's experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, according to interim...
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Five Stocks To Buy: Federal Bank, GAIL, Eicher Motors And More | June 16, 2026

Market analysts and brokerage firms have identified high-conviction trading ideas for the upcoming session, focusing on private banking, ene...